| CPC A61K 31/353 (2013.01) [A61P 31/14 (2018.01); C12N 9/99 (2013.01)] | 4 Claims |
|
1. A method of inhibiting the activity of MERS-papain-like protease (PLpro), comprising:
administering a therapeutically effective amount of a pharmaceutical composition consisting of fisetin and a pharmaceutically acceptable carrier to a subject in need thereof; and
binding fisetin to the MERS-papain-like protease (PLpro).
|